PAPP-A as a marker of increased long-term risk in patients with chest pain

Clinical Biochemistry

Volumn 42, Issue 10-11, 2009, Pages 1012-1018

  Kavsak, Peter A ^a   Wang, Xuesong ^b   Henderson, Matthew ^a   Ko, Dennis T ^b   MacRae, Andrew R ^c   Jaffe, Allan S ^d  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d MAYO CLINIC   (United States)

Author keywords

Cardiac troponin; Death; Emergency department; High sensitivity; Pregnancy associated plasma protein A

Indexed keywords

BIOCHEMICAL MARKER; PREGNANCY ASSOCIATED PLASMA PROTEIN A; TROPONIN C;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CHEMICAL ANALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EARLY DIAGNOSIS; EMERGENCY WARD; FEMALE; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SENSITIVITY ANALYSIS; THORAX PAIN;

AGED; BIOLOGICAL MARKERS; CHEST PAIN; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 67349164638     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.03.015     Document Type: Article

References (36)

1. Morrow D.A., Cannon C.P., Jesse R.L., Newby L.K., Ravkilde J., Storrow A.B., et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin. Chem. 53 (2007) 552-574
2. Thygesen K., Alpert J.S., and White H.D. Joint ESC/AACF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. J. Am. Coll. Cardiol. 50 (2007) 2173-2195
3. Lee T.H., Rouan G.W., Weisberg M.C., Brand D.A., Acampora D., Stasiulewicz C., et al. Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency room. Am. J. Cardiol. 60 (1987) 219-224
4. Pope J.H., Aufderheide T.P., Ruthazer R., Woolard R.H., Feldman J.A., Beshansky J.R., et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N. Engl. J. Med. 342 (2000) 1163-1170
5. Worster A., Devereaux P.J., Heels-Ansdell D., Guyatt G.H., Opie J., Mookadam F., et al. Capability of ischemia-modified albumin to predict serious outcomes in the short term among patients with potential acute coronary syndrome. CMAJ 172 (2005) 1685-1690
6. Kaul P., Chang W.C., Westerhout C.M., Graham M.M., and Armstrong P.W. Differences in admission rates and outcomes between men and women presenting to emergency departments with coronary syndromes. CMAJ 177 (2007) 1193-1199
7. Bonaca M.P., and Morrow D.A. Defining a role for novel biomarkers in acute coronary syndromes. Clin. Chem. 54 (2008) 1424-1431
8. MacRae A.R., Kavsak P.A., Lustig V., Bhargava R., Vandersluis R., Palomaki G.E., et al. Assessing the requirement for the 6-hour interval between specimens in the American Heart Association classification of myocardial infarction in epidemiology and clinical research studies. Clin. Chem. 52 (2006) 812-818
9. Sabatine M.S., Morrow D.A., de Lemos J.A., Gibson C.M., Murphy S.A., Rifai N., et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 105 (2002) 170-173
10. Wiviott S.D., Cannon C.P., Morrow D.A., Murphy S.A., Gibson C.M., McCabe C.H., et al. Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 substudy. Cicrculation 109 (2004) 580-586
11. Bodi V., Sanchis J., Llacer A., Facila L., Nunex J., Pellicer M., et al. Multimarker risk strategy for predicting 1-month and 1-year major events in non-ST-elevation acute coronary syndromes. Am. Heart J. 149 (2005) 268-274
12. James S.K., Lindahl B., Timmer J.R., Ottervanger J.P., Siegbahn A., Stridsberg M., et al. Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy). Am. J. Cardiol. (2006) 167-172
13. Apple F.S., Pearce L.A., Chungn A., Ler R., and Murakami M.M. Multiple biomarker use for detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin. Chem. 53 (2007) 874-881
14. Kavsak P.A., Newman A.M., Lustig V., MacRae A.R., Palomaki G.E., Ko D.T., et al. Long-term health outcomes associated with detectable troponin I concentrations. Clin. Chem. 53 (2007) 220-227
15. Kavsak P.A., MacRae A.R., Newman A.M., Lustig V., Palomaki G.E., Ko D.T., et al. Elevated C-reactive protein in acute coronary syndrome presentation is an independent predictor of long-term mortality and heart failure. Clin. Biochem. 40 (2007) 326-329
16. Kavsak P.A., Ko D.T., Newman A.M., Lustig V., Palomaki G.E., MacRae A.R., et al. Vascular versus myocardial dysfunction in acute coronary syndrome: are the adhesion molecules as powerful as NT-proBNP for long-term risk stratification?. Clin. Biochem. 41 (2008) 436-439
17. Apple F.S., Wu A.H., Mair J., Ravkilde J., Panteghini M., Tate J., et al. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin. Chem. 51 (2005) 810-824
18. Bayes-Genis A., Conover C.A., Overgaard M.T., Bailey K.R., Christiansen M., Holmes D.R., et al. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N. Engl. J. Med. 345 (2001) 1022-1029
19. Qin Q.P., Wittfooth S., and Pettersson K. Measurement and clinical significance of circulating PAPP-A in ACS patients. Clin. Chim. Acta 380 (2007) 59-67
20. Kavsak P.A., MacRae A.R., Lustig V., Bhargava R., Vandersluis R., Palomaki G., et al. The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction. Am. Heart J. 152 (2006) 118-125
21. Kavsak P.A., MacRae A.R., Palomaki G.E., Newman A.M., Ko D.T., Lustig V., et al. Health outcomes categorized by current and previous definitions of acute myocardial infarction in an unselected cohort of troponin-naïve emergency department patients. Clin. Chem. 52 (2006) 2028-2035
22. Kavsak P.A., MacRae A.R., Yerna M.J., and Jaffe A.S. Analytical and clinical utility of a next generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury. Clin. Chem. 55 (2009) 573-577
23. Laursen L.S., Overgaard M.T., Weyer K., Boldt H.B., Ebbesen P., Christiansen M., et al. Cell surface targeting of pregnancy-associated plasma protein A proteolytic activity. J. Biol. Chem. 277 (2002) 47225-47234
24. Terkelsen C.J., Oxvig C., Borgaard B.L., Glerup S., Poulsen T.S., Lassen J.F., et al. Temporal course of pregnancy-associated plasma protein-A in angioplasty-treated ST-elevation myocardial infarction patients and potential significance of concomitant heparin administration. Am. J. Cardiol. 103 (2009) 29-35
25. Qin Q.P., Kokkala S., Lund J., Tamm N., Voipio-Pulkki L.M., and Pettersson K. Molecular distinction of circulating pregnancy-associated plasma protein A in myocardial infarction and pregnancy. Clin. Chem. 51 (2005) 75-83
26. Consuegra-Sanchez L., Fredericks S., and Kaski J.C. Pregnancy-associated plasma protein-A (PAPP-A) and cardiovascular risk. Atherosclerosis 12 (2008 Aug) [Electronic publication ahead of print]
27. Conti E., Carrozza C., Capoluongo E., Volpe M., Crea F., Zuppi C., et al. Insulin-like growth factor-1 as a vascular protective factor. Circulation 110 (2004) 2260-2265
28. Crea F., and Andreotti F. Pregnancy associated plasma protein-A and coronary atherosclerosis: marker, friend, or foe?. Eur. Heart J. 26 (2005) 2075-2076
29. Cosin-Sales J., Christiansen M., Kaminski P., Oxvig C., Overgaard M.T., Cole D., et al. Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris. Circulation 109 (2004) 1724-1728
30. Cosin-Sales J., Kaski J.C., Christiansen M., Kaminski P., Oxvig C., Overgaard M.T., et al. Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris. Eur. Heart J. 26 (2005) 2093-2098
31. Lund J., Qin Q.P., Ilva T., Pettersson K., Voipio-Pulkki L.M., Porela P., et al. Circulating Pregnancy-associated plasma protein A predicts outcome in patients with acute coronary syndrome but no troponin I elevation. Circulation 108 (2003) 1924-1926
32. Heeschen C., Dimmeler S., Hamm C.W., Fichtlscherer S., Simoons M.L., and Zeiher A.M. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J. Am. Coll. Cardiol. 45 (2005) 229-237
33. Consuegra-Sanchez L., Petrovic I., Cosin-Sales J., Holt D.W., Christiansen M., and Kaski J.C. Prognostic value of circulating pregnancy-associated plasma protein-A (PAPP-A) and proform of eosinophil major basic protein (pro-MBP) levels in patients with chronic stable angina pectoris. Clin. Chim. Acta 391 (2008) 18-23
34. Miedema M.D., Conover C.A., MacDonald H., Harrington S.C., Oberg D., Wilson D., et al. Pregnancy associated plasma protein-A elevation in patients with acute coronary syndrome and subsequent atorvastatin therapy. Am. J. Cardiol. 1001 (2008) 35-39
35. Ridker P.M., Cannon C.P., Morrow D., Rifai N., Rose L.M., McCabe C.H., et al. C-reactive protein levels and outcomes after statin therapy. N. Engl. J. Med. 352 (2005) 20-28
36. Morrow D.A., de Lemons J.A., Sabatine M.S., Wiviott S.D., Blazing M.A., Shui A., et al. Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial. Circulation 114 (2006) 281-288